TY  - JOUR
T1  - Post-operative adjuvant treatment in carcinoma gall bladder: A brief review
A1  - Pramod Singh
A1  - Rakesh Kapoor
A1  - Ritesh Kumar
A1  - Amit Bahl
A1  - Narendra Kumar
A1  - Rajesh Gupta
A1  - Suresh Sharma
JF  - Clinical Cancer Investigation Journal
JO  - Clin Cancer Investig J
SN  - 2278-0513
Y1  - 2014
VL  - 3
IS  - 3
DO  - 10.4103/2278-0513.132108
SP  - 196
EP  - 199
N2  - Gallbladder cancer (GBC) represents the most common malignancy among the biliary tree cancers representing 3% of such tumors. Complete surgical resection offers the best chance for cure. Adjuvant chemotherapy and radiotherapy are less well-defined and need to be further evaluated to increase local and systemic control. Local recurrences as high as 75% have been reported after radical cholecystectomy in GBC. The patterns of failure and poor overall prognosis in GBC, justify administration of adjuvant treatments. Only an estimated 20% of patients receive radiotherapy or chemotherapy after resection and fewer than 10% of all presenting patients undergo surgery, radiotherapy and chemotherapy. Recent series have suggested that local-regional control and possibly ultimate outcome can be improved by the use of adjuvant therapy.
UR  - https://ccij-online.org/article/post-operative-adjuvant-treatment-in-carcinoma-gall-bladder:-a-brief-review-207
ER  -